| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
vinita_dubey [2022/01/06 10:50]
liam | vinita_dubey [2022/01/29 23:47] (current)
liam |
|---|
| ==== Ontario Immunization Advisory Committee ==== | ==== Ontario Immunization Advisory Committee ==== |
| |
| Dubey is a member of the [[Ontario Immunization Advisory Committee]] (OIAC), formed in August 2021 at the request of Ontario's Chief Medical Officer of Health Dr. [[Kieran Moore]]. "The focus of the Committee’s work is on publicly-funded vaccines and immunization programs in Ontario, including COVID-19, and those under consideration for new programming."((Public Health Ontario. //Ontario Immunization Advisory Committee (OIAC).// Retrieved November 9, 2021, from https://www.publichealthontario.ca/en/about/our-organization/external-advisory-committees/oiac)) The committee operates under [[Public Health Ontario]]. | Dubey is a member of the [[Ontario Immunization Advisory Committee]] (OIAC), formed in August 2021 at the request of Ontario's Chief Medical Officer of Health Dr. [[Kieran Moore]]. "The focus of the Committee’s work is on publicly-funded vaccines and immunization programs in Ontario, including COVID-19, and those under consideration for new programming."((Public Health Ontario. //Ontario Immunization Advisory Committee (OIAC).// Retrieved November 10, 2021, from https://archive.ph/v0lpJ)) The committee operates under [[Public Health Ontario]]. |
| |
| ==== Toronto Public Health ==== | ==== Toronto Public Health ==== |
| |
| Dubey has been employed by [[Toronto Public Health]] as Associate Medical Officer of Health since 2006, in Communicable Diseases.((Dalla Lana School of Public Health. (2016, September 26). //Dubey, Vinita.// Retrieved November 3, 2021, from https://www.dlsph.utoronto.ca/faculty-profile/dubey-vinita/)) She works under [[Eileen De Villa]], who has familial financial ties to pharmaceutical companies including [[Pfizer]], [[AstraZeneca]], [[Bayer]], [[Eli Lilly]], [[HLS Therapeutics]], [[Novartis]], [[Sanofi]] and [[Servier]].((Verma, S., MD, PhD, FRCSC, FAHA, Choi, R., MD, FRCPC, Bucci, C., PharmD, & Gupta, A., MD, FRCPC. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications [Slides].// CardioVascUpdate. https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf)) ((Staley, G. (2021, March 4). //Toronto’s Medical Officer, Dr. Eileen De Villa’s husband has financial relationships with major vaccine manufacturers – is this a conflict of interest?// Diverge Media. Retrieved November 2, 2021, from https://divergemedia.ca/2021/03/04/torontos-medical-officer-dr-eileen-de-villas-husband-has-financial-relationships-with-major-vaccine-manufacturers-is-this-a-conflict-of-interest/)) ((McGovern, C. (2021, March 8). //Toronto lockdown czar’s husband has ‘financial ties’ to Pfizer, AstraZeneca.// LifeSiteNews. Retrieved November 2, 2021, from https://www.lifesitenews.com/news/toronto-lockdown-czars-husband-has-financial-ties-to-pfizer-astrazeneca/)) | Dubey has been employed by [[Toronto Public Health]] as Associate Medical Officer of Health since 2006, in Communicable Diseases.((Dalla Lana School of Public Health. (2016, September 26). //Dubey, Vinita.// Retrieved November 3, 2021, from https://www.dlsph.utoronto.ca/faculty-profile/dubey-vinita/)) She works under [[Eileen De Villa]], who has familial financial ties to pharmaceutical companies including [[pharmaceutical_companies:pfizer|Pfizer]], [[AstraZeneca]], [[Bayer]], [[Eli Lilly]], [[HLS Therapeutics]], [[Novartis]], [[Sanofi]] and [[Servier]].((Verma, S., MD, PhD, FRCSC, FAHA, Choi, R., MD, FRCPC, Bucci, C., PharmD, & Gupta, A., MD, FRCPC. (2020, June 12). //Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications [Slides].// CardioVascUpdate. https://cardiovascupdate.ca/files/2020/CV%20Update%20Symposium-Presentation.pdf)) ((Staley, G. (2021, March 4). //Toronto’s Medical Officer, Dr. Eileen De Villa’s husband has financial relationships with major vaccine manufacturers – is this a conflict of interest?// Diverge Media. Retrieved November 2, 2021, from https://divergemedia.ca/2021/03/04/torontos-medical-officer-dr-eileen-de-villas-husband-has-financial-relationships-with-major-vaccine-manufacturers-is-this-a-conflict-of-interest/)) ((McGovern, C. (2021, March 8). //Toronto lockdown czar’s husband has ‘financial ties’ to Pfizer, AstraZeneca.// LifeSiteNews. Retrieved November 2, 2021, from https://www.lifesitenews.com/news/toronto-lockdown-czars-husband-has-financial-ties-to-pfizer-astrazeneca/)) |
| |
| Dubey has appeared on public platforms multiple times to advocate for restrictive public health measures and COVID-19 vaccine products, as well as vaccine passports. She also warned against treating COVID-19. | Dubey has appeared on public platforms multiple times to advocate for restrictive public health measures and COVID-19 vaccine products, as well as vaccine passports. She also warned against treating COVID-19. |
| === HELPinKids&Adults === | === HELPinKids&Adults === |
| |
| She is also a member of the [[HELPinKids&Adults]] team, a group that advises medical practitioners and institutions on reducing pain during vaccination. Their partners include the [[Canadian Nursing Coalition for Immunization]] (CNCI), [[Canadian Pharmacists Association]] (CPA), [[Canadian Public Health Association]] (CPHA), [[College of Family Physicians of Canada]] (CFPC), [[Immunize Canada]], [[Canadian Center for Vaccinology]], and the [[BC Centre for Disease Control]] (BCCDC).((HELPinKids&Adults. (2019). //About Us.// University of Toronto. https://archive.ph/9NCqH)) The group is also associated with the [[World Health Organization]] (WHO), the [[Brighton Collaboration]], the [[Public Health Agency of Canada]] (PHAC), [[CANVax]], [[Kids Boost Immunity]] (funded by [[Pfizer]], [[Merck]], [[Sanofi]], [[gsk|GlaxoSmithKline]], [[CANImmunize]] and others). | She is also a member of the [[helpinkids|HELPinKids&Adults]] team, a group that advises medical practitioners and institutions on reducing pain during vaccination. Their partners include the [[Canadian Nursing Coalition for Immunization]] (CNCI), [[Canadian Pharmacists Association]] (CPA), [[Canadian Public Health Association]] (CPHA), [[College of Family Physicians of Canada]] (CFPC), [[Immunize Canada]], [[Canadian Center for Vaccinology]], and the [[BC Centre for Disease Control]] (BCCDC).((HELPinKids&Adults. (2019). //About Us.// University of Toronto. https://archive.ph/9NCqH)) The group is also associated with the [[World Health Organization]] (WHO), the [[Brighton Collaboration]], the [[Public Health Agency of Canada]] (PHAC), [[CANVax]], [[Kids Boost Immunity]] (funded by [[pharmaceutical_companies:pfizer|Pfizer]], [[Merck]], [[Sanofi]], [[gsk|GlaxoSmithKline]], [[CANImmunize]] and others). |
| |
| ===== Publications ===== | ===== Publications ===== |
| |
| * [[https://www.campfire.wiki/lib/exe/fetch.php?media=it_takes_time_to_build_trust_a_survey_ontario_s_school_based_hpv_immunization_program_ten_years_post_implementation.pdf|July 9, 2020]]: “It takes time to build trust”: a survey Ontario’s school-based HPV immunization program ten years post-implementation.((Dubé, E., Wilson, S., Gagnon, D., Deeks, S. L., & Dubey, V. (2020). //“It takes time to build trust”: a survey Ontario’s school-based HPV immunization program ten years post-implementation.// Human Vaccines & Immunotherapeutics, 1–6. https://doi.org/10.1080/21645515.2020.1775456)) | * [[https://www.campfire.wiki/lib/exe/fetch.php?media=it_takes_time_to_build_trust_a_survey_ontario_s_school_based_hpv_immunization_program_ten_years_post_implementation.pdf|July 9, 2020]]: “It takes time to build trust”: a survey Ontario’s school-based HPV immunization program ten years post-implementation.((Dubé, E., Wilson, S., Gagnon, D., Deeks, S. L., & Dubey, V. (2020). //“It takes time to build trust”: a survey Ontario’s school-based HPV immunization program ten years post-implementation.// Human Vaccines & Immunotherapeutics, 1–6. https://doi.org/10.1080/21645515.2020.1775456)) |
| * Funded by a grant from the Canadian Immunization Research Network, which is itself funded by [[Pfizer]], [[Sanofi]] and [[gsk|GlaxoSmithKline]].((Canadian Immunization Research Network (CIRN). (2018, February 26). //Partners | CIRN.// Retrieved November 25, 2021, from https://cirnetwork.ca/about-us/partners/)) | * Funded by a grant from the Canadian Immunization Research Network, which is itself funded by [[pharmaceutical_companies:pfizer|Pfizer]], [[Sanofi]] and [[gsk|GlaxoSmithKline]].((Canadian Immunization Research Network (CIRN). (2018, February 26). //Partners | CIRN.// Retrieved November 25, 2021, from https://cirnetwork.ca/about-us/partners/)) |
| |
| * [[https://www.sciencedirect.com/science/article/pii/S0264410X19304840?via%3Dihub|May 21, 2019]]: //Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016–2017 school year.//((Wilson, S. E., Murray, J., Bunko, A., Johnson, S., Buchan, S. A., Crowcroft, N. S., Dubey, V., Loh, L. C., MacLeod, M., Taylor, C., & Deeks, S. L. (2019). //Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016–2017 school year.// Vaccine, 37(23), 3123–3132. https://doi.org/10.1016/j.vaccine.2019.04.033)) | * [[https://www.sciencedirect.com/science/article/pii/S0264410X19304840?via%3Dihub|May 21, 2019]]: //Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016–2017 school year.//((Wilson, S. E., Murray, J., Bunko, A., Johnson, S., Buchan, S. A., Crowcroft, N. S., Dubey, V., Loh, L. C., MacLeod, M., Taylor, C., & Deeks, S. L. (2019). //Characteristics of immunized and un-immunized students, including non-medical exemptions, in Ontario, Canada: 2016–2017 school year.// Vaccine, 37(23), 3123–3132. https://doi.org/10.1016/j.vaccine.2019.04.033)) |
| * [[https://www.tandfonline.com/doi/full/10.1080/16506073.2016.1157204|March 23, 2016]]: //Exposure-based Interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research.//((McMurtry, C. M., Taddio, A., Noel, M., Antony, M. M., Chambers, C. T., Asmundson, G. J. G., Pillai Riddell, R., Shah, V., MacDonald, N. E., Rogers, J., Bucci, L. M., Mousmanis, P., Lang, E., Halperin, S., Bowles, S., Halpert, C., Ipp, M., Rieder, M. J., Robson, K., & Uleryk, E. (2016). //Exposure-based Interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research.// Cognitive Behaviour Therapy, 45(3), 217–235. https://doi.org/10.1080/16506073.2016.1157204)) | * [[https://www.tandfonline.com/doi/full/10.1080/16506073.2016.1157204|March 23, 2016]]: //Exposure-based Interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research.//((McMurtry, C. M., Taddio, A., Noel, M., Antony, M. M., Chambers, C. T., Asmundson, G. J. G., Pillai Riddell, R., Shah, V., MacDonald, N. E., Rogers, J., Bucci, L. M., Mousmanis, P., Lang, E., Halperin, S., Bowles, S., Halpert, C., Ipp, M., Rieder, M. J., Robson, K., & Uleryk, E. (2016). //Exposure-based Interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research.// Cognitive Behaviour Therapy, 45(3), 217–235. https://doi.org/10.1080/16506073.2016.1157204)) |
| * Endorsed/supported by: | * Endorsed/supported by: |
| * Canadian Public Health Association (CPHA), which is itself funded by Pfizer, Moderna, AstraZeneca, Merck, Johnson & Johnson, Sanofi, Seqirus, VBI Vaccines, GlaxoSmithKline and various others. | * [[Canadian Public Health Association]] (CPHA), which is itself funded by [[pharmaceutical_companies:pfizer|Pfizer]], [[Moderna]], [[AstraZeneca]], [[Merck]], [[Johnson & Johnson]], [[Sanofi]], [[Seqirus]], [[VBI Vaccines]], [[gsk|GlaxoSmithKline]] and various others. |
| * Immunize Canada, which is itself sponsored by Pfizer, Moderna, Merck, GlaxoSmithKline, Sanofi and Seqirus. | * [[Immunize Canada]], which is itself sponsored by [[pharmaceutical_companies:pfizer|Pfizer]], [[Moderna]], [[Merck]], [[gsk|GlaxoSmithKline]], [[Sanofi]] and [[Seqirus]].(( Member Organizations (2021, October 18). Immunize Canada. https://immunize.ca/member-organizations)) |
| * Canadian Center for Vaccinology, which is running clinical trials for COVID-19 vaccine products by Moderna, VBI Vaccines, Pfizer and AstraZeneca, as well as other COVID-related studies with Sinai Health System, Dalhousie University and other pro-vaccination entities. | * [[Canadian Center for Vaccinology]], which is running clinical trials for [[COVID-19]] vaccine products by [[Moderna]], [[VBI Vaccines]], [[pharmaceutical_companies:pfizer|Pfizer]] and [[AstraZeneca]], as well as other COVID-related studies with [[Sinai Health System]], [[Dalhousie University]] and other pro-vaccination entities. |
| * Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials | |
| * Funded by the Canadian Institutes of Health Research (CIHR) | * [[https://www.hindawi.com/journals/cjidmm/2011/381864/|2011]]: //Practices and Perceptions Regarding Pain and Pain Management during Routine Childhood Immunizations: Findings from a Focus-Group Study with Nurses Working at Toronto Public Health, Ontario.//((Kikuta, A., Gardezi, F., Dubey, V., & Taddio, A. (2011). //Practices and Perceptions Regarding Pain and Pain Management during Routine Childhood Immunizations: Findings from a Focus-Group Study with Nurses Working at Toronto Public Health, Ontario.// Canadian Journal of Infectious Diseases and Medical Microbiology, 22(2), 43–48. https://doi.org/10.1155/2011/381864)) |
| * Practices and Perceptions Regarding Pain and Pain Management during Routine Childhood Immunizations: Findings from a Focus-Group Study with Nurses Working at Toronto Public Health, Ontario | |
